HEMATOLOGICAL RECOVERY AFTER HIGH-DOSE CYCLOPHOSPHAMIDE (CTX) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

被引：0
|
作者：
TWELVES, CJ
SOUHAMI, RL
HARPER, PG
GOLDSTONE, A
机构：
[1] GUYS HOSP, CLIN ONCOL UNIT, LONDON SE1 9RT, ENGLAND
[2] UNIV COLL HOSP LONDON, DEPT ONCOL, LONDON WC 1, ENGLAND
[3] UNIV COLL HOSP LONDON, DEPT HAEMATOL, LONDON WC 1, ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [21] HIGH-DOSE BUSULPHAN/CYCLOPHOSPHAMIDE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH MINIMAL NONHEMATOPOIETIC TOXICITY
    ROSENTHAL, MA
    GRIGG, AP
    SHERIDAN, WP
    LEUKEMIA & LYMPHOMA, 1994, 14 (3-4) : 279 - 283
  • [22] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MYELOMA
    MCELWAIN, TJ
    SELBY, PJ
    GORE, ME
    VINER, C
    MELDRUM, M
    MILLAR, BC
    MALPAS, JS
    EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPL NO 51, VOL 43, 1989: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MULTIPLE MYELOMA - BIOLOGY, PATHOPHYSIOLOGY, PROGNOSIS AND TREATMENT, 1989, : 152 - 156
  • [23] OVERVIEW OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    SANTOS, GW
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 215 - 216
  • [24] IMMUNE RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    IMRIE, K
    COLWILL, R
    STEWART, AK
    CRUMP, M
    NISBETBROWN, E
    CARSTAIRS, K
    KEATING, A
    LIPTON, J
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 782 - 782
  • [25] TREATMENT OF SMALL CELL BRONCHOGENIC (SCBC) WITH HIGH-DOSE CHEMOTHERAPY (CT) AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    FARHA, P
    SPITZER, G
    VALDIVIESO, M
    ZANDER, A
    VERMA, D
    MINNHAAR, G
    VELLEKOOP, L
    DICKE, K
    BODEY, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 496 - 496
  • [26] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MYELOMA
    MCELWAIN, TJ
    SELBY, PJ
    GORE, ME
    VINER, C
    MELDRUM, M
    MILLAR, BC
    MALPAS, JS
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 : 152 - 156
  • [27] HIGH-DOSE BCNU WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) AND LOCALIZED RADIOTHERAPY FOR PATIENTS WITH HIGH-GRADE ASTROCYTOMAS
    COLOMBAT, P
    LINASSIER, C
    CALAIS, G
    VELUT, S
    SAUDEAU, D
    DETOFFOL, B
    JAN, M
    AUTRET, A
    LAMAGNERE, JP
    BIRON, P
    BONE MARROW TRANSPLANTATION, 1992, 10 : 42 - 42
  • [28] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN LYMPHOMA
    PHILLIPS, GL
    FAY, JW
    HERZIG, GP
    HERZIG, RH
    LAZARUS, HM
    WOLFF, SN
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 217 - 217
  • [29] MODIFICATION OF MARROW CELL IMMUNOPHENOTYPE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
    DOMENECH, J
    LINASSIER, C
    CANEPA, S
    BURASCHI, JP
    DESBOIS, I
    BREMOND, JL
    COLOMBAT, P
    LAMAGNERE, JP
    BINET, C
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 562 - 562
  • [30] ESCALATING THE MELPHALAN DOSE IN A REGIMEN INCLUDING HIGH-DOSE ETOPOSIDE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT ASSOCIATED WITH ENHANCED TOXICITY
    SHER, GD
    COLWILL, R
    COUTURE, F
    STEWART, K
    CRUMP, M
    KEATING, A
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1130 - 1130
12345